ID CLB HC.PH.BIO.CLB
Develops drugs, biologics or cell and gene therapies with no approved product on the market (no revenue, or milestones only); such a developer is here, not in contract research.
Sector, group and industry above this class, as placed in the current release. The sector and the industry link to their companies.
Companies whose primary class this is. The sector and industry pages and the screener count them the same way.
| Company | Ticker | Country | Market cap | Filings |
|---|---|---|---|---|
| BELLICUM PHARMACEUTICALS, INC Delisted | — | United States of America | — | 606 |
| ALSERES PHARMACEUTICALS INC Delisted | — | United States of America | — | 604 |
| Panbela Therapeutics, Inc. Delisted | — | United States of America | — | 596 |
| 康乐卫士 | 920575 | China | — | 594 |
| Reunion Neuroscience Inc. Delisted | REUN | Canada | — | 593 |
| Hemostemix Inc. | HEM | Canada | — | 592 |
| Modalis Therapeutics Corporation | 4883 | Japan | — | 592 |
| 9 Meters Biopharma Inc Delisted | INNT | United States of America | — | 591 |
| FutureChem Co., Ltd. | 220100 | South Korea | — | 589 |
| SICHUAN BIOKIN PHARMACEUTICAL CO., LTD. | 688506 | China | — | 586 |
| Lin BioScience, Inc. | 6696 | Taiwan | — | 580 |
| Cellular Biomedicine Group Inc Delisted | CBMG | United States of America | — | 576 |
| Concert Pharmaceuticals Inc Delisted | CNCE | United States of America | — | 574 |
| Idenix Pharmaceuticals Inc Delisted | IDIX | United States of America | — | 574 |
| Hepion Pharmaceuticals Inc | HEPA | United States of America | — | 570 |
| SAMSRITA LABS LIMITED | 539267 | India | — | 570 |
| Neose Technologies Inc Delisted | NTEC1 | United States of America | — | 568 |
| Simris Group AB | SIMRIS | Sweden | — | 568 |
| Eutilex Co.,Ltd. | 263050 | South Korea | — | 566 |
| OliX Pharmaceuticals, Inc. | 226950 | South Korea | — | 564 |
| CHIMERIC THERAPEUTICS LIMITED | CHM | Australia | — | 561 |
| Core One Labs Inc. | COOL | Canada | — | 560 |
| Genome&Company | 314130 | South Korea | — | 559 |
| Kringle Pharma,Inc. | 4884 | Japan | — | 559 |
| Alar Pharmaceuticals Inc. | 6785 | Taiwan | — | 558 |
| APPLIED GENETIC TECHNOLOGIES CORP Delisted | — | United States of America | — | 555 |
| Resverlogix Corp. | RVX | Canada | — | 555 |
| Allakos Inc Delisted | ALLK | United States of America | — | 554 |
| PHARMOS CORP Delisted | — | United States of America | — | 552 |
| Conatus Pharmaceuticals Inc Delisted | CNAT | United States of America | — | 550 |
| Anacor Pharmaceuticals, Inc. Delisted | — | United States of America | — | 547 |
| ACCENTIA BIOPHARMACEUTICALS INC Delisted | — | United States of America | — | 546 |
| Gene Biotherapeutics, Inc. Delisted | — | United States of America | — | 546 |
| NGM Biopharmaceuticals Inc Delisted | NGM | United States of America | — | 545 |
| Aevi Genomic Medicine LLC Delisted | GNMX_old | United States of America | — | 539 |
| ICAGEN INC Delisted | — | United States of America | — | 539 |
| SCM Lifescience Co., Ltd. | 298060 | South Korea | — | 539 |
| PROLOR Biotech, Inc. Delisted | — | United States of America | — | 537 |
| VIA Pharmaceuticals, Inc. Delisted | — | United States of America | — | 537 |
| NEXALIS THERAPEUTICS LTD | NX1 | Australia | — | 535 |
| StemRIM Inc. | 4599 | Japan | — | 535 |
| ContraFect Corp Delisted | CFRX | United States of America | — | 533 |
| Alder BioPharmaceuticals Inc Delisted | ALDR | United States of America | — | 532 |
| U.S. Stem Cell, Inc. Delisted | — | United States of America | — | 532 |
| CAMBIUM BIO LIMITED | CMB | Australia | — | 531 |
| NervGen Pharma Corp. | NGEN | Canada | — | 530 |
| BioArctic | BIOA | Sweden | — | 528 |
| Calithera Biosciences, Inc. Delisted | — | United States of America | — | 524 |
| Sierra Oncology Inc Delisted | SRRA | United States of America | — | 524 |
| JIANGSU YAHONG MEDITECH CO., LTD. | 688176 | China | — | 522 |
Other names for this activity, and where neighboring activities go instead.
preclinicaldrug developer
Research-led company whose approved medicines, which it discovered, are in one or two therapeutic areas; it moves to Branded Prescription Drugs only after two consecutive annual reports with approved products in three or more.
https://financialfilings.com/oics/CLB/
This page is keyed by the class ID CLB. IDs are assigned in v0.3 and freeze at v1.0; from then on an ID is never renamed or reused, and if the class moves in the tree, its ID and this URL stay the same.
Sign in or create a free account - no password needed.
By continuing, you agree to our Terms and Privacy Policy.